Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 1.00 |
| ▸ | BACE1 | P56817 | 8/20 | 0.89 |
| ▸ | APP | P05067 | 7/20 | 0.89 |
| ▸ | MAPT | P10636 | 7/20 | 0.89 |
| ▸ | MMP9 | P14780 | 5/20 | 0.89 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.89 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.89 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.89 |
| ▸ | TSHR | P16473 | 2/20 | 0.89 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.89 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.89 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.89 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.89 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.89 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.89 |
| ▸ | STAT3 | P40763 | 2/20 | 0.89 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13521973 | 1.00 | ABCB1 (1.00) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| SCHEMBL21327853 | 1.00 | ABCB1 (1.00) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| SCHEMBL2553051 | 1.00 | ABCB1 (1.00) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| Curcumin SCHEMBL28278390 | 0.99 | ABCB1 (0.97) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| SCHEMBL23176040 | 0.95 | ABCB1 (0.90) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| Curcumin SCHEMBL2303947 | 0.95 | ABCB1 (0.90) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| Curcumin SCHEMBL250984 | 0.94 | APP (1.00) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| Curcumin SCHEMBL2804734 | 0.94 | APP (1.00) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| Curcumin SCHEMBL8440 | 0.94 | APP (1.00) | ABCB1AKR1B1MAOAMAOBBACE1 | |
| Curcumin SCHEMBL6901740 | 0.94 | APP (1.00) | ABCB1AKR1B1MAOAMAOBBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20240183526-A1 | SYSTEMS, DEVICES, AND METHODS FOR A BOILER HEALTH AND CARBON-FOOTPRINT MONITOR TOOL | SAUDI ARABIAN OIL COMPANY (SA) | 2024-06-06 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-105030623-B | Maca facial mask | 上海悦萌环保科技有限公司 | 2018-01-23 | — | — | CN | claimed |
| CN-105078833-B | Maca facial mask, pleura and preparation method thereof | 广东长昊药业股份有限公司 | 2017-12-08 | — | — | CN | claimed |
| US-20160354504-A1 | MALODOR COUNTERACTING COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2016-12-08 | — | — | US | claimed |
| EP-3101171-A1 | MALODOR COUNTERACTING COMPOSITIONS | International Flavors & Fragrances Inc. (US) | 2016-12-07 | — | — | EP | claimed |
| EP-1978984-B1 | NUTRITIONAL SYSTEM AND METHODS FOR INCREASING LONGEVITY | NESTEC SA (CH) | 2015-06-10 | — | — | EP | claimed |
| US-20130316029-A1 | METHODS AND COMPOSITIONS SUITABLE FOR MANAGING BLOOD GLUCOSE IN ANIMALS | NESTEC S.A. (CH) | 2013-11-28 | — | — | US | claimed |
| EP-2654777-A2 | METHODS AND COMPOSITIONS SUITABLE FOR MANAGING BLOOD GLUCOSE IN ANIMALS | Nestec S.A. (CH) | 2013-10-30 | — | — | EP | claimed |
| WO-2012087742-A2 | METHODS AND COMPOSITIONS SUITABLE FOR MANAGING BLOOD GLUCOSE IN ANIMALS | NESTEC S.A. (CH) | 2012-06-28 | — | — | WO | claimed |
| WO-2012057824-A1 | METHODS AND COMPOSITIONS SUITABLE FOR PROMOTING HEALTHY SKIN | NESTEC S.A. (CH) | 2012-05-03 | — | — | WO | claimed |
| US-20090000734-A1 | Method For Producing a Cladding Element | INTERGLARION LIMITED (CY) | 2009-01-01 | — | — | US | claimed |
| EP-1978984-A2 | NUTRITIONAL SYSTEM AND METHODS FOR INCREASING LONGEVITY | NESTEC S.A. (CH) | 2008-10-15 | — | — | EP | claimed |
| US-20070231371-A1 | Nutritional system and methods for increasing longevity | NESTEC, S. A. | 2007-10-04 | — | — | US | claimed |
| WO-2007088046-A2 | NUTRITIONAL SYSTEM AND METHODS FOR INCREASING LONGEVITY | NESTEC S.A. (CH) | 2007-08-09 | — | — | WO | claimed |
| CN-1908300-A | Application of curcuma longa in paper and paperboard making | HUANG HUAXIN (CN) | 2007-02-07 | — | — | CN | claimed |
| CN-1908085-A | Application of curcuma in coating manufacture | HUANG HUAXIN (CN) | 2007-02-07 | — | — | CN | claimed |
| CN-1241997-C | Purification process for improving total yield of curcuminoid colouring agent | HANSENS LAB (DK) | 2006-02-15 | — | — | CN | claimed |
| CN-1447839-A | Purification process for improving total yield of curcuminoid colouring agent | HANSENS LAB (DK) | 2003-10-08 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160354504-A1 | MALODOR COUNTERACTING COMPOSITIONS | LPO, MAL2, ME1 | ABCB1 4411/4885AKR1B1 550/4885MAOA 1117/4885 |
| US-20070231371-A1 | Nutritional system and methods for increasing longevity | AGER, GCKR, IGFBP1 | ABCB1 4883/4885AKR1B1 869/4885MAOA 3101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.